Premier Alternatives

Lightcast (Biotechnology)

Cambridge, United Kingdom · Founded 2019 · Privately Held (backing)

Developer of a microfluidic technology designed to manipulate individual microscopic droplets encapsulating cells with flexibility. Lightcast (Biotechnology) is based in Cambridge, United Kingdom and was founded in 2019. Its last reported valuation was $139 million in Jul 2024. It has raised $141 million.

Last reported valuation
$138.9M
Oct 2026
Priced at
—
Total raised
$140.9M
Last round
—

Lightcast (Biotechnology) key facts

as of Oct 2026
  • Developer of a microfluidic technology designed to manipulate individual microscopic droplets encapsulating cells with flexibility.
  • Lightcast (Biotechnology) is valued at approximately $138.9M as of Oct 2026 (last reported valuation).
  • It has raised $140.9M; the latest was Later Stage VC ($27.0M) in Apr 2026.
  • Notable investors include ARCH Venture Partners, M Ventures, Illumina Ventures, Perscitus, Longwall Ventures — 9 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$138.9M

Lightcast (Biotechnology)'s last reported valuation, Jul 2024. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Lightcast (Biotechnology) with a free account
  • ·Watch Lightcast (Biotechnology): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Lightcast (Biotechnology) funding rounds

No rounds on record

No funding rounds for Lightcast (Biotechnology) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Lightcast (Biotechnology) valuation

Lightcast (Biotechnology)'s last reported valuation was $139 million in Jul 2024. No priced round, secondary trade or fund mark has surfaced since.

Lightcast (Biotechnology) investors

9 investors are on record for Lightcast (Biotechnology), including ARCH Venture Partners, M Ventures, Illumina Ventures and Perscitus.

About Lightcast (Biotechnology)

Developer of a microfluidic technology designed to manipulate individual microscopic droplets encapsulating cells with flexibility. The company's technology helps to detect and automatically count the number of cells in each droplet, and the droplets can be organized to perform parallel, sequential assays with multiple readouts, enabling healthcare clients to perform workflows and allow specific droplets of interest to be dispensed while maintaining viable cells in the dispensed droplets.

Sector
Healthcare
HQ
Cambridge, United Kingdom
Founded
2019
Employees
100
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.